关注
Elena Cavarretta
Elena Cavarretta
在 uniroma1.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
microRNAs in cardiovascular diseases: current knowledge and the road ahead
G Condorelli, MVG Latronico, E Cavarretta
Journal of the American College of Cardiology 63 (21), 2177-2187, 2014
4482014
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy
R Roncarati, C Viviani Anselmi, MA Losi, L Papa, E Cavarretta, ...
Journal of the American College of Cardiology 63 (9), 920-927, 2014
3612014
Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection: a scoping review
F Infusino, M Marazzato, M Mancone, F Fedele, CM Mastroianni, ...
Nutrients 12 (6), 1718, 2020
2202020
A 20-year experience with mitral valve repair with artificial chordae in 608 patients
L Salvador, S Mirone, R Bianchini, T Regesta, F Patelli, G Minniti, ...
The Journal of thoracic and cardiovascular surgery 135 (6), 1280-1287. e1, 2008
2032008
Acute effects of Heat‐Not‐Burn, electronic Vaping, and traditional tobacco combustion cigarettes: the Sapienza University of Rome‐Vascular assessment of proatherosclerotic …
G Biondi‐Zoccai, S Sciarretta, C Bullen, C Nocella, F Violi, L Loffredo, ...
Journal of the American Heart Association 8 (6), e010455, 2019
1842019
Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study
S De Castro, S Caselli, M Maron, A Pelliccia, E Cavarretta, P Maddukuri, ...
Heart 93 (2), 205-209, 2007
1072007
Impairment between oxidant and antioxidant systems: short-and long-term implications for athletes’ health
C Nocella, V Cammisotto, F Pigozzi, P Borrione, C Fossati, A D’Amico, ...
Nutrients 11 (6), 1353, 2019
932019
Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: a position statement of the sport cardiology and exercise …
PE Adami, N Koutlianos, A Baggish, S Bermon, E Cavarretta, ...
European Journal of Preventive Cardiology 29 (3), 559-575, 2022
90*2022
Deregulation of Notch1 pathway and circulating endothelial progenitor cell (EPC) number in patients with bicuspid aortic valve with and without ascending aorta aneurysm
CR Balistreri, F Crapanzano, L Schirone, A Allegra, C Pisano, G Ruvolo, ...
Scientific reports 8 (1), 13834, 2018
622018
SARS-CoV-2 and COVID-19. Facing the pandemic together as citizens and cardiovascular practitioners
G Biondi-Zoccai, G Landoni, R Carnevale, E Cavarretta, S Sciarretta, ...
Minerva cardioangiologica 68 (2), 61-64, 2020
612020
Remodelling of the left ventricle in athlete’s heart: a three dimensional echocardiographic and magnetic resonance imaging study
S De Castro, A Pelliccia, S Caselli, ED Angelantonio, F Papetti, ...
Heart 92 (7), 975-976, 2006
542006
Morphological and chemical study of pathological deposits in human aortic and mitral valve stenosis: a biomineralogical contribution
V Cottignoli, E Cavarretta, L Salvador, C Valfré, A Maras
Pathology Research International 2015 (1), 342984, 2015
532015
Cardiac remodeling in obese patients after laparoscopic sleeve gastrectomy
E Cavarretta, G Casella, B Calì, C Dammaro, G Biondi-Zoccai, A Iossa, ...
World journal of surgery 37, 565-572, 2013
522013
Echocardiographic findings in 2261 peri-pubertal athletes with or without inverted T waves at electrocardiogram
L Calò, F Sperandii, A Martino, E Guerra, E Cavarretta, F Quaranta, ...
Heart 101 (3), 193-200, 2015
512015
Usefulness of tricuspid annular velocity in identifying global RV dysfunction in patients with primary pulmonary hypertension: a comparison with 3D echo‐derived right …
S De Castro, E Cavarretta, A Milan, S Caselli, E Di Angelantonio, ...
Echocardiography 25 (3), 289-293, 2008
502008
Extracorporeal membrane oxygenation for critically ill patients with coronavirus-associated disease 2019: an updated perspective of the European experience.
AG Marullo, E Cavarretta, M Mancone, M Peruzzi, F Piscioneri, P Sartini, ...
Minerva Cardioangiologica 68 (5), 368-372, 2020
492020
miR-21 and cardiac fibrosis: another brick in the wall?
E Cavarretta, G Condorelli
European heart journal 36 (32), 2139-2141, 2015
492015
Pathological biominerals: Raman and infrared studies of bioapatite deposits in human heart valves
S Mangialardo, V Cottignoli, E Cavarretta, L Salvador, P Postorino, ...
Applied Spectroscopy 66 (10), 1121-1127, 2012
492012
MicroRNAs in coronary heart disease: ready to enter the clinical arena?
E Cavarretta, G Frati
BioMed Research International 2016 (1), 2150763, 2016
482016
The role of antioxidants supplementation in clinical practice: focus on cardiovascular risk factors
V Cammisotto, C Nocella, S Bartimoccia, V Sanguigni, D Francomano, ...
Antioxidants 10 (2), 146, 2021
472021
系统目前无法执行此操作,请稍后再试。
文章 1–20